Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome-Reference-Cited by-同舟云学术

Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome

Published:2014-08 Issue:8 Volume:20 Page:455-459
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Mori Masaaki,Morio Tomohiro,Ito Shuichi,Morimoto Akira,Ota Setsuo,Mizuta Koichi,Iwata Tsutomu,Hara Toshiro,Saji Tsutomu

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference38 articles.

1. Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan;Mori;Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy,2011

2. Respiratory syncytial viral infection in children with compromised immune function;Hall;The New England Journal of Medicine,1986

3. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study;Kristensen;Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America,2012

4. Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome;Delage;Archives of Pathology & Laboratory Medicine,1984

5. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection;Welliver;The Journal of Pediatrics,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of respiratory syncytial virus on older children: Exploring the potential for preventive strategies beyond the age of 2 years;Vaccine;2024-08

2. Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial;The Lancet Regional Health - Western Pacific;2023-10

3. Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia;BMC Pediatrics;2022-07-27

4. Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency;Anales de Pediatría (English Edition);2022-06

5. Infecciones por virus respiratorio sincitial que requieren hospitalización en pacientes con inmunodeficiencias primarias;Anales de Pediatría;2021-12